We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Johns Hopkins and Fraunhofer-Gesellschaft Institute Join Forces

By HospiMedica staff writers
Posted on 15 Jul 2008
Johns Hopkins University (JHU, Baltimore, MD, USA) has established formal research collaboration with the Fraunhofer-Gesellschaft Institute (Munich, Germany), which will bridge biomedicine and engineering to develop new surgical and diagnostic tools. More...


Under the agreement, the new initiative for "Innovations in Interventional Medicine” will bring together researchers from the Johns Hopkins University School of Medicine and the Whiting School of Engineering with biomedical engineers at Fraunhofer to develop new minimally invasive surgical tools. The initial phase of the collaboration will focus on three projects: the development of a computer-aided endoscopy tool that can help diagnose gastrointestinal disease; a laparoscopic surgery tool that will align pre-operative computerized tomography (CT) scans during surgery; and a new system that will be used to track endoscopes and surgical tools during medical procedures.

"This agreement provides a wonderful opportunity for researchers from the two institutions to work together to develop important new medical tools and move them out of the lab and into applications where they can help patients,” said Kristina M. Johnson, provost and senior vice president for academic affairs at JHU. "Joining Johns Hopkins' expertise in basic research with Fraunhofer's skills in applied technology should result in a very productive international partnership.”

"Although this collaboration will initially focus on these three specific projects, we expect that the underlying technology developed can be applied to a broad spectrum of interventional and diagnostic medicine,” said Elliot McVeigh, director of biomedical engineering at JHU. "Perhaps more importantly, the goal of this joint effort is to develop a long-term working relationship with teams of engineers at Fraunhofer that will bring new medical technologies into practice more rapidly.”

The Fraunhofer-Gesellschaft, comprised of more than 80 research units at 40 different locations throughout Germany, undertakes applied research of direct utility to private and public enterprise, and is the largest organization for applied research in Europe. Of the EUR 1.3 billion annual research budget of the institute, more than EUR 1 billion is generated through contract research, derived from contracts with industry and from publicly financed research projects. The rest of the budget is contributed by the German federal and Länder [state] governments.


Related Links:
Johns Hopkins University
Fraunhofer-Gesellschaft

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.